Dalton, Greiner, Hartman, Maher & Co’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-851,752
Closed -$20.2M 192
2015
Q4
$20.2M Sell
851,752
-4,917
-0.6% -$114K 1.16% 27
2015
Q3
$17.1M Buy
856,669
+139,903
+20% +$2.8M 0.96% 38
2015
Q2
$13.9M Buy
716,766
+193,823
+37% +$4.01M 0.72% 64
2015
Q1
$11.8M Sell
522,943
-4,536
-0.9% -$104K 0.66% 61
2014
Q4
$11.4M Buy
527,479
+4,139
+0.8% +$88.2K 0.63% 66
2014
Q3
$10.6M Sell
523,340
-19,865
-4% -$432K 0.6% 66
2014
Q2
$11.9M Buy
543,205
+27,254
+5% +$579K 0.62% 68
2014
Q1
$10.6M Sell
515,951
-5,697
-1% -$112K 0.61% 70
2013
Q4
$9.45M Buy
521,648
+9,258
+2% +$175K 0.55% 78
2013
Q3
$9.53M Buy
512,390
+117,237
+30% +$2.3M 0.65% 66
2013
Q2
$7.99M Buy
+395,153
New +$8.55M 0.61% 71

Other funds holding BMR

Dalton, Greiner, Hartman, Maher & Co's BMR Position: Q1 2016 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 851,752 shares — an estimated $20.2M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $20.2M in Q4 2015. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 851,752 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $20.2M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's BIOMED REALTY TRUST INC position peaked at $20.2M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q1 2016, filed 14 Apr 2016.